KALYNNE SPINKS: Open Payments
NPI 1588346589 · HALFMOON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,509 in 90 payments from 24 companies in 2025. Trend: 2023 $410 · 2024 $1,648 · 2025 $2,509
Food & beverage: $2,509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $509 |
| Novo Nordisk Inc | 9 | $414 |
| AstraZeneca Pharmaceuticals LP | 9 | $294 |
| Lilly USA, LLC | 10 | $283 |
| GlaxoSmithKline, LLC. | 7 | $229 |
| Abbott Laboratories | 4 | $191 |
| Amgen Inc. | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| SANOFI PASTEUR INC. | 2 | $42 |
Products named: Ozempic, SHINGRIX, UBRELVY, FREESTYLE LIBRE 3, VRAYLAR, ZEPBOUND, BREZTRI, QULIPTA.
Industry payments across NY — which companies pay providers there.
